Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
subcutaneous drug delivery
Pharma
Vertex taps Halozyme in $15M upfront biologics drug delivery deal
Halozyme is putting a recent drug delivery acquisition to work, thanks to a new tie-up with Vertex Pharmaceuticals.
Fraiser Kansteiner
Apr 7, 2026 10:17am
On-body injected version of Amgen's Tepezza measures up to IV
Apr 6, 2026 9:43am
Biogen taps Alteogen for help developing 2 subQ biologics
Mar 25, 2026 10:55am
Halozyme catches M&A wave to snap up Surf Bio
Jan 28, 2026 2:06pm
GSK licenses Alteogen enzyme in bid to develop subQ Jemperli
Jan 20, 2026 2:26pm
Roche's bispecific Lunsumio goes subcutaneous
Dec 22, 2025 10:15am
